Browse Subject Areas

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Efficient Conversion of Phenylpyruvic Acid to Phenyllactic Acid by Using Whole Cells of Bacillus coagulans SDM

  • Zhaojuan Zheng,

    Affiliation State Key Laboratory of Microbial Technology, Shandong University, Jinan, People's Republic of China

  • Cuiqing Ma , (CM); (PX)

    Affiliation State Key Laboratory of Microbial Technology, Shandong University, Jinan, People's Republic of China

  • Chao Gao,

    Affiliation MOE Key Laboratory of Microbial Metabolism and School of Life Sciences and Biotechnology, Shanghai Jiao Tong University, Shanghai, People's Republic of China

  • Fengsong Li,

    Affiliation State Key Laboratory of Microbial Technology, Shandong University, Jinan, People's Republic of China

  • Jiayang Qin,

    Affiliation State Key Laboratory of Microbial Technology, Shandong University, Jinan, People's Republic of China

  • Haiwei Zhang,

    Affiliation State Key Laboratory of Microbial Technology, Shandong University, Jinan, People's Republic of China

  • Kai Wang,

    Affiliation State Key Laboratory of Microbial Technology, Shandong University, Jinan, People's Republic of China

  • Ping Xu (CM); (PX)

    Affiliations State Key Laboratory of Microbial Technology, Shandong University, Jinan, People's Republic of China, MOE Key Laboratory of Microbial Metabolism and School of Life Sciences and Biotechnology, Shanghai Jiao Tong University, Shanghai, People's Republic of China

Efficient Conversion of Phenylpyruvic Acid to Phenyllactic Acid by Using Whole Cells of Bacillus coagulans SDM

  • Zhaojuan Zheng, 
  • Cuiqing Ma, 
  • Chao Gao, 
  • Fengsong Li, 
  • Jiayang Qin, 
  • Haiwei Zhang, 
  • Kai Wang, 
  • Ping Xu



Phenyllactic acid (PLA), a novel antimicrobial compound with broad and effective antimicrobial activity against both bacteria and fungi, can be produced by many microorganisms, especially lactic acid bacteria. However, the concentration and productivity of PLA have been low in previous studies. The enzymes responsible for conversion of phenylpyruvic acid (PPA) into PLA are equivocal.

Methodology/Principal Findings

A novel thermophilic strain, Bacillus coagulans SDM, was isolated for production of PLA. When the solubility and dissolution rate of PPA were enhanced at a high temperature, whole cells of B. coagulans SDM could effectively convert PPA into PLA at a high concentration (37.3 g l−1) and high productivity (2.3 g l−1 h−1) under optimal conditions. Enzyme activity staining and kinetic studies identified NAD-dependent lactate dehydrogenases as the key enzymes that reduced PPA to PLA.


Taking advantage of the thermophilic character of B. coagulans SDM, a high yield and productivity of PLA were obtained. The enzymes involved in PLA production were identified and characterized, which makes possible the rational design and construction of microorganisms suitable for PLA production with metabolic engineering.


Phenyllactic acid (PLA) has broad and effective antimicrobial activity against both bacteria and fungi and can therefore be employed and developed as a new type of natural antiseptic agent to extend the shelf life of food and feed [1][3]. It is also a useful precursor for the synthesis of many important drugs, including Danshensu (3,4-dihydroxyphenyllactic acid) which can inhibit platelet aggregation and coronary artery disease, hypoglycemic reagents, protease inhibitors, and anti-HIV reagents [4][8]. Because of its wide use in food and pharmaceutical industries, PLA production has attracted the attention of biotechnologists.

Chemical and biotechnological routes have been developed for PLA production. The chemical transformation strategy has some disadvantages, including a complex technology route, excessive by-products, and environmental pollution [9], [10]. Regarding the requirement for environmental protection and sustainable development, biotransformation has emerged as a powerful strategy for the production of this valuable compound [11]. Recently, several microorganisms, including Geotrichum candidum, propionibacteria, and lactic acid bacteria (LAB) were found to be PLA producers [12][18].

Many studies have focused on the ability of LAB to produce PLA because LAB have GRAS (generally recognized as safe) status. LAB, especially Lactobacillus strains, yielded PLA at the low level of 0.05–0.57 mM via the phenylalanine (Phe) metabolic pathway [19], [20]. The transamination reaction in the Phe pathway was the bottleneck for PLA formation [20], and the use of phenylpyruvic acid (PPA) as a substitute substrate led to a 14-fold increase in PLA production [21]. PPA showed obvious inhibitory effects in the biotransformation process, and therefore, fed-batch fermentation could be conducted for producing a high amount of PLA. It should be noted that PPA powder must be dissolved beforehand because of its slow dissolution rate at the biotransformation temperature [21]. PLA concentration was significantly increased with the application of this strategy [22].

PLA is the acknowledged reduction product of PPA, but the enzymes responsible for this reaction remain unclear. In previous studies, hydroxyisocaproate dehydrogenase (HicDH), phenyllactic acid dehydrogenase (PLDHase), and d-lactate dehydrogenase (d-LDH) of Lactobacillus were assumed to be involved in PLA production from PPA [19], [23][26].

In this study, a thermophilic strain, Bacillus coagulans SDM, was isolated and its ability to produce PLA from PPA was confirmed. The enzymes involved in the production of PLA were identified and characterized. In addition, with the enhanced solubility and dissolution rate of PPA at the high reaction temperature, a high concentration, yield and productivity of PLA were obtained in fed-batch bioconversion.


Isolation of thermophilic bacteria for PLA production

Using the procedures described in Materials and Methods, 560 bacterial strains that grew at 50°C were tested for PLA production. Strain SDM showed the highest PLA production rate among the isolates and was selected for a detailed study. Identification of the strain was confirmed by Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH (DSMZ). The pattern of the fatty acid analysis was typical for Bacillus and suggested B. coagulans. Identification of the strain SDM as B. coagulans was also supported by the partial 16S rRNA sequence (GenBank accession number: HQ171055). The strain was deposited at the China Center for Type Culture Collection (CCTCC NO: M 2010012).

Optimization of biotransformation by whole cells of B. coagulans SDM

By using the thermophilic property of B. coagulans SDM, bioconversion of PLA from PPA was studied at a relatively high temperature. The reaction was carried out at 100 rpm for 0.5 h in phosphate buffer solution (PBS, 1/15 M [pH 7.4]) containing whole cells of B. coagulans SDM, PPA, and glucose. The optimal pH value was determined to be 6.5 (Figure 1a) and the optimal temperature was determined to be 50°C (Figure 1b). The optimal PPA concentration was determined to be 40 mM (Figure 1c) and substrate inhibition was observed at higher PPA concentrations. The effect of biomass concentration on PLA production was investigated and the highest specific bioconversion rate of PLA was obtained with 28 grams dry cell weight (DCW) per liter (OD620 nm = 50) (Figure 1d). The effect of the cell growth phase on PLA production was also optimized and the middle exponential phase showed the highest PLA production rate (Table 1).

Figure 1. Optimization of bioconversion conditions.

(a) Effect of pH on PLA production. (b) Effect of temperature on PLA production. (c) Effect of PPA concentration on PLA production. (d) Effect of biomass concentration on the specific bioconversion rate of PLA.

Production of PLA from PPA with substrate feeding

Fed-batch bioconversion was conducted with intermittent substrate feeding to avoid substrate inhibition. The bioconversion process was performed in a 5-l bioreactor (BIOSTAT B, B. Braun Biotech International GmbH, Germany) containing 2-l reaction mixtures. PPA was added in the solid form because of the observed enhanced dissolution of PPA at the high temperature. The initial concentrations of PPA and glucose were 6.6 g 1−1 (40 mM) and 36 g 1−1, respectively. The pH was maintained at 6.5 by addition of NaOH solution. PPA and glucose powders were supplemented to maintain the initial concentrations by a pulse-feeding strategy.

The time course of PLA production from PPA was shown in Figure 2. A total of 105 g PPA and 252 g glucose were added to the 2-l reaction mixtures in this experiment. In addition to PLA, lactic acid was co-produced throughout the bioconversion process. The final PLA and lactic acid concentrations were 37.3 g 1−1 and 66 g 1−1, respectively. The average productivity of PLA was 2.3 g 1−1 h−1 and the yield was 70%.

Figure 2. Time course of production of PLA from PPA under optimum conditions.

Symbols represent: ▴, PLA; •, PPA; ▪, lactic acid; □, glucose.

Identification of enzymes responsible for conversion of PPA into PLA

The conversion between PPA and PLA is a redox reaction. To identify the enzymes responsible for the production of PLA, activity staining of the enzymes that catalyzed PLA oxidation was carried out. As shown in Figure 3 (lane 1), no PLA oxidation activity was detected without NAD addition. In the presence of NAD, two bands with distinct mobilities were presented when dl-PLA was used as the substrate (Figure 3, lane 2). The activities responsible for l- and d-lactate oxidation were also studied because of the co-production of lactic acid throughout the bioconversion process. The two bands exhibiting l- and d-lactate oxidation activities were located at the same positions as the two enzymes involved in l- and d-PLA oxidation, respectively (Figure 3). Since the biotransformation of lactic acid from pyruvic acid is catalyzed by the NAD-dependent lactate dehydrogenases (nLDHs), the results of activity staining implied that the enzymes responsible for PPA reduction present in B. coagulans SDM are nLDHs.

Figure 3. Native polyacrylamide gel electrophoresis staining for PLA and lactate oxidation activities.

Symbol (−) represents solutions without NAD addition and symbol (+) represents solutions with 5 mM NAD. dl-PLA was used as substrate for active staining in lane 1 and 2, whereas l-PLA, dl-lactate, and l-lactate were used as substrates in lane 3, 4, and 5, respectively. All substrates were used at a concentration of 50 mM.

Activities of l-nLDH and d-nLDH in PPA reduction

To further identify the function of nLDHs in PLA production activities in strain SDM, the nLDHs were purified and further characterized. At present, only one genome of the B. coagulans strain, B. coagulans 36D1, has been released. Analysis of the genome of B. coagulans 36D1 identified one l-nLDH (accession number at GenBank, ZP_04430752) and one d-nLDH (accession number at GenBank, ZP_04430367). By using these two genes as guides for designing primers, the ldhL gene (GenBank accession number: HQ148709) and ldhD gene (GenBank accession number: HQ148710) of B. coagulans SDM were cloned.

The amino acid sequences of the cloned nLDHs were deduced from the nucleotide sequences, and l-nLDH and d-nLDH exhibited considerable homology with other reported l-nLDHs and d-nLDHs of LAB, respectively (Figure S1 and Figure S2). Multiple alignments with other reported l-nLDHs showed that all catalytically important residues (Arg 109, Asp 168, Arg 171, and His 195) were conserved in the B. coagulans SDM l-nLDH (Figure S1) [27]. Moreover, the amino acids involved in activation by fructose 1,6-bisphosphate (FDP) (Arg 173 and His 188) were also found in l-nLDH (Figure S1) [28]. The essential residues of d-nLDH (Arg 235, Glu 264, and His 296) were also conserved in the B. coagulans SDM d-nLDH (Figure S2) [29], [30].

The catalytic efficiencies of the recombinant nLDHs were determined by the reduction of pyruvate or PPA. Although notable differences in the catalytic activities were observed, both pyruvate and PPA could be catalyzed by the l-nLDH and d-nLDH of B. coagulans SDM (Table 2). The catalytic efficiencies of l-nLDH and d-nLDH on pyruvate were 40-fold and 3-fold higher than on PPA, respectively. A possible explanation is that PPA has a larger group at the C3-position, which results in a substrate that is unfavorable compared with pyruvate [31][33].


In previous studies, PPA as the direct precursor of PLA was used as a substitute for Phe to enhance PLA production [21]. PPA is difficult to dissolve at a low temperature or under acidic and neutral conditions. This problem was solved by dissolving PPA with 2 M NaOH beforehand and adjusting the pH of the media by acid after the PPA solution was added [21]. In this study, a B. coagulans strain that transformed PPA to PLA efficiently at 50°C was isolated. PPA powder was directly added to the reaction mixture by using a pulse-feeding strategy in the fed-batch bioconversion. The rapid dissolution of PPA and the high metabolic activity at higher temperature resulted in a higher concentration and yield of PLA in B. coagulans SDM compared with other reported producers (Table 3).

The enzymes responsible for PPA reduction were uncertain in previous studies. HicDH was shown to catalyze the reduction of aromatic α-keto acids to the corresponding hydroxyl acids in the amino acid catabolism of many LAB [26]. In some studies, it was assumed that PLDHase was responsible for reducing PPA to PLA during Phe catabolism in LAB [23], [25]. Recently, a d-LDH from the PLA producing strain, Lactobacillus sp. SK007, was purified and its reducing activity on PPA was detected [19]. In this study, the enzymes responsible for PPA reduction were identified as l-nLDH and d-nLDH through enzyme activity staining and kinetic analysis.

A cosubstrate was necessary to supply NADH because conversion of PPA to PLA was accompanied by the oxidation of NADH to NAD. In general, glucose is a good carbon source for cofactor regeneration because of its commercial availability, low price, and excellent bioavailability. Therefore, glucose was used for cofactor regeneration in this study. The biotransformation was conducted as follows: NADH was produced from glycolysis and PPA was reduced to PLA via nLDH-catalyzed reduction (Figure 4). Because both pyruvate and PPA are the substrates of nLDHs (Figure 4), the pyruvate derived from glucose would be expected to compete against PPA for binding to nLDHs and produce a mass of lactic acid (Figure 2). For a substrate such as PPA with larger groups at the C3-position, the catalytic efficiencies of nLDHs were markedly decreased (Table 2) [31][33]. Overcoming this bottleneck by redesign of the wild-type enzymes would significantly improve PLA production.

In conclusion, PLA is efficiently produced from PPA by the novel thermophilic strain B. coagulans SDM. In fed-batch bioconversion, 37.3 g 1−1 PLA was obtained from 52.5 g 1−1 PPA in 16 h at 50°C. The enzymes responsible for PPA reduction were further examined and identified as l-nLDH and d-nLDH. Illustrating this problem makes it possible to rationally modify microorganisms that are suitable for PLA production through metabolic engineering.

Materials and Methods

Isolation of thermotolerant bacteria

Soil samples were collected from chemical plants, farmlands, gardens, and dust heaps. Approximately 1 g of each sample was enriched in 50 ml of a liquid medium (GYSC) containing (g l-1): glucose (50), yeast extract (10), soybean peptone (5), and CaCO3 (20). The samples were incubated at 50°C and 100 rpm for 8 h, and an aliquot of the suspension was plated on GYSC solid medium and incubated at 50°C until multiple colonies emerged. Representative colonies were selected and incubated in GYSC liquid medium at 50°C and 100 rpm. After 8 h, 1% PPA (w/v) was added to the medium. The reaction mixtures were incubated for another 8 h, centrifuged at 4,500 rpm for 15 min, and the supernatant was analyzed for PPA and PLA. The strain that produced the highest amounts of PLA was designated SDM.

Biotransformation by whole cells of strain SDM

For whole cell preparation, overnight precultures of strain SDM were inoculated into fresh GYSC liquid medium with 10% inoculum and the cultures were incubated at 50°C and 100 rpm. Cells were harvested by centrifugation at 4,500 rpm for 15 min, washed with PBS, and resuspended in the same buffer to form cell suspensions. The biotransformation reactions were performed in 50-ml flasks containing 10 ml of the reaction mixtures. Parameters varied as follows for optimization of the reaction conditions: pH values were 5–8. Temperatures were 40–60°C. PPA concentrations were 8–80 mM, and cell concentrations were 14–56 g DCW 1−1. The time of harvesting cells was set at early exponential phase, middle exponential phase, late exponential phase, and stationary phase. After completion of the reactions, the samples were heated to 100°C and centrifuged. The concentrations of PPA and PLA in the resulting supernatants were quantitatively analyzed by high-performance liquid chromatography (HPLC).

Activity staining after native polyacrylamide gel electrophoresis (PAGE)

To identify the enzyme activities for PLA production in B. coagulans SDM, cells were harvested, washed, resuspended in PBS, and disrupted by sonication in an ice bath. The disrupted cells were centrifuged for 40 min at 13,000 rpm and the supernatant was used as the crude cell extract for native PAGE. Native PAGE was carried out at 4°C on a 10% native polyacrylamide gel. Active staining was performed after native PAGE according to a previous method with some modifications [34]. The gel was cut into five parts after electrophoresis and soaked in different solutions containing 100 mM Tris-HCl buffer (pH 8.3), 0.15 mM phenazine methanosulfate (PMS), 0.15 mM nitro blue tetrazolium (NBT), and corresponding substrates. Chemically reduced NBT dye by enzymatically produced NADH was precipitated as a dark blue band that was easily seen in the stained gels.

Bacterial strains, plasmids, and growth conditions

Escherichia coli strains and plasmids used in this study are listed in Table 4. E. coli was grown at 37°C in Luria-Bertani (LB) medium and kanamycin was added at a concentration of 50 µg m1−1, if necessary.

Recombinant protein production and purification

The ldhL and ldhD genes were amplified by PCR using genomic DNA of B. coagulans SDM as the template. Primers were designed based on the genome sequences of B. coagulans 36D1. Primers P1 and P2 were used for ldhL amplification and primers P3 and P4 were used for ldhD amplification (Table 4). The resulting PCR products were digested with HindIII-XhoI and cloned into the HindIII-XhoI sites of pET-28a to construct plasmids pET28a-ldhL and pET28a-ldhD. For protein expression, E. coli BL21(DE3) harboring recombinant plasmid was incubated in LB media (containing 50 µg m1−1 kanamycin) at 37°C with shaking. When the culture reached an optical density of 0.6 at 600 nm, 1 mM isopropyl-β-d-thiogalactopyranoside (IPTG) was added to induce gene expression. After induction at 25°C for 5 h, cells were harvested and suspended in the binding buffer (200 mM sodium phosphate, 500 mM sodium chloride, and 20 mM imidazole [pH 7.4]) and disrupted by sonication. The suspension was centrifuged to remove cell debris. The resultant supernatant was filtered and loaded onto a HisTrap HP 5 ml column (GE Healthcare) and the enzyme was eluted with 60% binding buffer and 40% elution buffer (200 mM sodium phosphate, 500 mM sodium chloride, and 500 mM imidazole [pH 7.4]) at a flow rate of 5 ml min−1. The fractions containing the enzyme were detected by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE). The protein concentration was determined by the Bradford method using bovine serum albumin for calibration [35].

Lactate dehydrogenase assay

Reduction activities of nLDHs on pyruvate or PPA were assayed at 50°C with freshly purified recombinant l/d-nLDHs. For the d-nLDH assay, the reaction mixture contained 50 mM Tris-HCl buffer (pH 7.0), 0.2 mM NADH, and 10 mM substrate. For the l-nLDH assay, the catalytic reaction mixtures contained all reagents mentioned above in addition to 5 mM FDP. One unit of l/d-nLDHs was defined as the amount that catalyzed the oxidation of 1 µmol of NADH per minute.

Analytical procedures

PPA and PLA were measured by HPLC (Agilent 1100 series, Hewlett-Packard, USA) equipped with an Agilent Zorbax SB-C18 column (150×4.6 mm, 5 µm) and a variable-wavelength detector at 210 nm. The mobile phase consisted of 1 mM H2SO4 and acetonitrile with a ratio of 85:15 (v/v) at a flow rate of 0.7 ml min−1 at 30°C.

Glucose and lactic acid concentrations were measured by HPLC equipped with a Bio-Rad Aminex HPX-87H column (300×7.8 mm) and a refractive index detector. Analysis was performed with a mobile phase of 10 mM H2SO4 at a flow rate of 0.4 ml min−1 at 55°C.

DCW was calculated from the optical density (OD620 nm) with a linear correlation factor (1 OD620 nm = 0.56 g DCW 1−1).

Supporting Information

Figure S1.

Multiple alignment of the amino acid sequences of l-nLDHs from selected species. Species and accession numbers of sequences are as follows: Lactobacillus casei ATCC 393 (Lcas), YP_001988625; Lactobacillus rhamnosus GG (Lrha), YP_003172269; Lactococcus lactis (Llac), AAB51674; Lactobacillus helveticus DPC 4571 (Lhel), YP_001576807; and B. coagulans SDM (Bcoa), this study.



Figure S2.

Multiple alignment of the amino acid sequences of d-nLDHs from selected species. Species and accession numbers of sequences are as follows: Lactobacillus johnsonii NCC 533 (Ljoh), NP_964061; Lactobacillus helveticus DSM 20075 (Lhel), ZP_05752035; Leuconostoc mesenteroides (Lmes), AAA99506; Lactobacillus pentosus ATCC 8041 (Lpen), BAA14352; and B. coagulans SDM (Bcoa), this study.



Author Contributions

Conceived and designed the experiments: ZZ CM CG PX. Performed the experiments: ZZ CG FL HZ KW. Analyzed the data: ZZ CM CG FL JQ PX. Contributed reagents/materials/analysis tools: JQ CM PX. Wrote the paper: ZZ CM PX.


  1. 1. Dieuleveux V, Lemarinier S, Guéguen M (1998) Antimicrobial spectrum and target site of d-3-phenyllactic acid. Int J Food Microbiol 40: 177–183.
  2. 2. Lavermicocca P, Valerio F, Visconti A (2003) Antifungal activity of phenyllactic acid against molds isolated from bakery products. Appl Environ Microbiol 69: 634–640.
  3. 3. Schnürer J, Magnusson J (2005) Antifungal lactic acid bacteria as biopreservatives. Trends Food Sci Technol 16: 70–78.
  4. 4. Zhou LM, Zuo Z, Chow MSS (2005) Danshen: an overview of its chemistry, pharmacology, pharmacokinetics, and clinical use. J Clin Pharmacol 45: 1345–1359.
  5. 5. Yang RX, Huang SY, Yan FF, Lu XT, Xing YF, et al. (2010) Danshensu protects vascular endothelia in a rat model of hyperhomocysteinemia. Acta Pharmacol Sin 31: 1395–1400.
  6. 6. Budt KH, Stowasser B, Knolle J, Ruppert D, Meichsner C, et al. (1991) Inhibitors of retroviral proteases. DE Patent 4,030, 350:
  7. 7. Kano S, Yuasa Y, Yokomatsu T, Shibuya S (1998) Highly stereocontrolled synthesis of the four individual stereoisomers of statine. J Org Chem 53: 3865–3868.
  8. 8. Urban FJ, Moore BS (1992) Synthesis of optically-active 2-benzyldihydrobenzopyrans for the hypoglycemic agent englitazone. J Heterocycl Chem 29: 431–438.
  9. 9. Morita H, Mori H (1996) Process for production of phenyllactic acid derivative. US Patent 5,684,186.
  10. 10. Wong HNC, Xu ZL, Chang HM, Lee CM (1992) A modified synthesis of (±)-β-aryllactic acids. Synthesis 8: 793–797.
  11. 11. Xiao ZJ, Lv CJ, Gao C, Qin JY, Ma CQ, et al. (2010) A novel whole-cell biocatalyst with NAD+ regeneration for production of chiral chemicals. PLoS ONE 5: e8860.
  12. 12. Dieuleveux V, Van Der Pyl D, Chataud J, Guéguen M (1998) Purification and characterization of anti-Listeria compounds produced by Geotrichum candidum. Appl Environ Microbiol 64: 800–803.
  13. 13. Lavermicocca P, Valerio F, Evidente A, Lazzaroni S, Corsetti A, et al. (2000) Purification and characterization of novel antifungal compounds from the sourdough Lactobacillus plantarum strain 21B. Appl Environ Microbiol 66: 4084–4090.
  14. 14. Lind H, Jonsson H, Schnürer J (2005) Antifungal effect of dairy propionibacteria-contribution of organic acids. Int J Food Microbiol 98: 157–165.
  15. 15. Magnusson J, Ström K, Roos S, Sjögren J, Schnürer J (2003) Broad and complex antifungal activity among environmental isolates of lactic acid bacteria. FEMS Microbiol Lett 219: 129–135.
  16. 16. Ström K, Sjögren J, Broberg A, Schnürer J (2002) Lactobacillus plantarum MiLAB 393 produces the antifungal cyclic dipeptides cyclo(l-Phe-l-Pro) and cyclo(l-Phe-trans-4-OH-l-Pro) and 3-phenyllactic acid. Appl Environ Microbiol 68: 4322–4327.
  17. 17. Thierry A, Maillard MB (2002) Production of cheese flavour compounds derived from amino acid catabolism by Propionibacterium freudenreichii. Lait 82: 17–32.
  18. 18. Valerio F, Lavermicocca P, Pascale M, Visconti A (2004) Production of phenyllactic acid by lactic acid bacteria: an approach to the selection of strains contributing to food quality and preservation. FEMS Microbiol Lett 233: 289–295.
  19. 19. Li XF, Jiang B, Pan BL, Mu WM, Zhang T (2008) Purification and partial characterization of Lactobacillus species SK007 lactate dehydrogenase (LDH) catalyzing phenylpyruvic acid (PPA) conversion into phenyllactic acid (PLA). J Agric Food Chem 56: 2392–2399.
  20. 20. Vermeulen N, Gánzle MG, Vogel RF (2006) Influence of peptide supply and cosubstrates on phenylalanine metabolism of Lactobacillus sanfranciscensis DSM20451T and Lactobacillus plantarum TMW1.468. J Agric Food Chem 54: 3832–3839.
  21. 21. Li XF, Jiang B, Pan BL (2007) Biotransformation of phenylpyruvic acid to phenyllactic acid by growing and resting cells of a Lactobacillus sp. Biotechnol Lett 29: 593–597.
  22. 22. Mu WM, Liu FL, Jia JH, Chen C, Zhang T, et al. (2009) 3-Phenyllactic acid production by substrate feeding and pH-control in fed-batch fermentation of Lactobacillus sp. SK007. Bioresour Technol 100: 5226–5229.
  23. 23. Gummalla S, Broadbent JR (2001) Tyrosine and phenylalanine catabolism by Lactobacillus cheese flavor adjuncts. J Dairy Sci 84: 1011–1019.
  24. 24. Hummel W, Schütte H, Kula MR (1983) Large scale production of d-lactate dehydrogenase for the stereospecific reduction of pyruvate and phenylpyruvate. Appl Microbiol Biotechnol 18: 75–85.
  25. 25. Marilley L, Casey MG (2004) Flavours of cheese products: metabolic pathways, analytical tools and identification of producing strains. Int J Food Microbiol 90: 139–159.
  26. 26. Yvon M, Rijnen L (2001) Cheese flavour formation by amino acid catabolism. Int Dairy J 11: 185–201.
  27. 27. Dunn CR, Wilks HM, Halsall DJ, Atkinson T, Clarke AR, et al. (1991) Design and synthesis of new enzymes based on the lactate dehydrogenase framework. Philos Trans R Soc London, Ser B 332: 177–184.
  28. 28. Arai K, Hishida A, Ishiyama M, Kamata T, Uchikoba H, et al. (2002) An absolute requirement of fructose 1,6-bisphosphate for the Lactobacillus casei l-lactate dehydrogenase activity induced by a single amino acid substitution. Protein Eng 15: 35–41.
  29. 29. Stoll VS, Kimber MS, Pai EF (1996) Insights into substrate binding by d-2-ketoacid dehydrogenases from the structure of Lactobacillus pentosus d-lactate dehydrogenase. Structure 4: 437–447.
  30. 30. Taguchi H, Ohta T (1993) Histidine 296 is essential for the catalysis in Lactobacillus plantarum d-lactate dehydrogenase. J Biol Chem 268: 18030–18034.
  31. 31. Arai K, Kamata T, Uchikoba H, Fushinobu S, Matsuzawa H, et al. (2001) Some Lactobacillus l-lactate dehydrogenases exhibit comparable catalytic activities for pyruvate and oxaloacetate. J Bacteriol 183: 397–400.
  32. 32. Razeto A, Kochhar S, Hottinger H, Dauter M, Wilson KS, et al. (2002) Domain closure, substrate specificity and catalysis of d-lactate dehydrogenase from Lactobacillus bulgaricus. J Mol Biol 318: 109–119.
  33. 33. Tokuda C, Ishikura Y, Shigematsu M, Mutoh H, Tsuzuki S, et al. (2003) Conversion of Lactobacillus pentosus d-lactate dehydrogenase to a d-hydroxyisocaproate dehydrogenase through a single amino acid replacement. J Bacteriol 185: 5023–5026.
  34. 34. Ma CQ, Gao C, Qiu JH, Hao JR, Liu WW, et al. (2007) Membrane-bound l- and d-lactate dehydrogenase activities of a newly isolated Pseudomonas stutzeri strain. Appl Microbiol Biotechnol 77: 91–98.
  35. 35. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248–254.